Company Encyclopedia
View More
name
DAJIAWEIKANG
301126.SZ
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products. The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages, drinks, and probiotic beverages; and cleansing and care products. In addition, it provides pharmaceutical logistics services; and operates reproductive hospitals.
384.48 B
301126.SZMarket value -Rank by Market Cap -/-

Financial Score

21/11/2025 Update
C
Health Care DistributorsIndustry
Industry Ranking21/25
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-0.27%D
    • Profit Margin-0.09%D
    • Gross Margin18.09%D
  • Growth ScoreC
    • Revenue YoY5.30%C
    • Net Profit YoY-110.18%E
    • Total Assets YoY8.28%B
    • Net Assets YoY0.71%C
  • Cash ScoreD
    • Cash Flow Margin-112602.11%E
    • OCF YoY5.30%C
  • Operating ScoreB
    • Turnover0.82B
  • Debt ScoreD
    • Gearing Ratio72.68%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    DAJIAWEIKANG: Vice President Li Yulan resigned for personal reasons

    On October 31st, DAJIAWEIKANG announced that the company's board of directors recently received the resignation report from the company's deputy general manager Li Yulan. Li Yulan applied to resign from her position as deputy general manager for personal reasons. Her original term was from October 17, 2023, to October 9, 2026. According to relevant regulations, Li Yulan's resignation report will take effect from the date it is delivered to the board of directors. After her resignation, Li Yulan will no longer hold any position in the company

    Zhitong·
    SZ
    301126
    -4.92%
    Zhitong·
    SZ
    301126
    -4.92%

    DAJIAWEIKANG released its performance for the first three quarters, with a net profit attributable to the parent company of 5.0974 million yuan, a decrease of 86.02%

    DAJIAWEIKANG released its Q3 2025 report, with operating revenue for the first three quarters amounting to 4.13 billion yuan, a year-on-year increase of 3.69%. The net profit attributable to the parent company was 5.0974 million yuan, a year-on-year decrease of 86.02%; the net profit excluding non-recurring gains and losses was 3.8818 million yuan, a year-on-year decrease of 89.02%. The basic earnings per share were 0.025 yuan

    Zhitong·
    SZ
    301126
    -4.92%
    Zhitong·
    SZ
    301126
    -4.92%

    DAJIAWEIKANG: Li Yulan completed a reduction of 0.017%

    DAJIAWEIKANG announced that Li Yulan plans to reduce her holdings by no more than 50,000 shares through centralized bidding from June 6, 2025, to September 5, 2025, accounting for 0.024%. She has already reduced her holdings by 5,000 shares, 15,000 shares, and 15,000 shares on June 6, July 30, and August 1, respectively, with average reduction prices of 11.01 yuan/share, 12.18 yuan/share, and 13.68 yuan/share, totaling a reduction of 35,000 shares, accounting for 0.017%. After the reduction, she holds 165,000 shares, accounting for 0.080%

    Zhitong·
    SZ
    301126
    -4.92%
    Zhitong·
    SZ
    301126
    -4.92%

    DAJIAWEIKANG released its performance for the first half of the year, with a net profit attributable to the parent company of 893,500 yuan, a decrease of 97.19%

    According to the Zhitong Finance APP, DAJIAWEIKANG released its semi-annual report for 2025, with operating revenue of 2.708 billion yuan, a year-on-year increase of 4.16%. The net profit attributable to shareholders of the listed company was 893,500 yuan, a year-on-year decrease of 97.19%. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 724,400 yuan. The basic earnings per share were 0.004 yuan

    Zhitong·
    SZ
    301126
    -4.92%
    Zhitong·
    SZ
    301126
    -4.92%

    DAJIAWEIKANG director Zhong Xuesong plans to reduce his holdings by no more than 1.7%

    According to the Zhitong Finance APP, DAJIAWEIKANG announced that the company's director Mr. Zhong Xuesong plans to reduce his shareholding by no more than 3.5 million shares (accounting for 1.70% of the company's total share capital) through centralized bidding or block trading from September 1, 2025, to November 30, 2025

    Zhitong·
    SZ
    301126
    -4.92%
    Zhitong·
    SZ
    301126
    -4.92%